"It showed me what a disadvantage I was at compared to people who don’t have obsessive thoughts about food. It never had ...

A popular class of drugs for treating diabetes and obesity reduces addiction, including abuse of alcohol, tobacco, cannabis, ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

Dieticians say that weight-loss drugs are leading to an increase in malnutrition and related conditions. Dieticians are ...

I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

"We felt it could have been a huge cost and a huge policy discussion," one GOP senator said of the move.

The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

New research to be presented suggests GLP-1 usage reduced the severity of migraines among those with chronic migraine. Here's ...

Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...